(CYTK) Cytokinetics - Performance -37.6% in 12m
CYTK performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
12.63%
#24 in Peer-Group
Rel. Strength
13.19%
#6663 in Stock-Universe
Total Return 12m
-37.56%
#114 in Peer-Group
Total Return 5y
42.34%
#26 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 60.16 USD |
| 52 Week Low | 29.84 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 94.06 |
| Buy/Sell Signal +-5 | 1.02 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CYTK (-37.6%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: CYTK vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CYTK
| Total Return (including Dividends) | CYTK | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 6.94% | 3.36% | 5.25% |
| 3 Months | -7.23% | 15.73% | 24.13% |
| 12 Months | -37.56% | -7.02% | 14.15% |
| 5 Years | 42.34% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | CYTK | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 46.2% | 4.4% | 81% |
| 3 Months | -49.3% | 78.8% | 96.9% |
| 12 Months | -95.1% | -85.8% | 44.9% |
| 5 Years | 67.7% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th70.00 | 3.47% | 1.61% |
| 3 Month | %th20.50 | -19.84% | -25.26% |
| 12 Month | %th43.50 | -32.84% | -45.30% |
| 5 Years | %th88.00 | 87.81% | -32.80% |
FAQs
Does Cytokinetics (CYTK) outperform the market?
No,
over the last 12 months CYTK made -37.56%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months CYTK made -7.23%, while XBI made 15.73%.
Performance Comparison CYTK vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CYTK vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.8% | 1.7% | -35.2% | -52% |
| US NASDAQ 100 | QQQ | 3% | 1.6% | -35.9% | -50% |
| German DAX 40 | DAX | 5% | 8.4% | -47.4% | -66% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3% | 3.7% | -38.6% | -57% |
| Hongkong Hang Seng | HSI | 3.2% | 0.9% | -54.7% | -76% |
| India NIFTY 50 | INDA | 4.7% | 3.5% | -35.5% | -37% |
| Brasil Bovespa | EWZ | 0.4% | -1.9% | -60.3% | -48% |
CYTK vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 4.2% | 1% | -39.3% | -62% |
| Consumer Discretionary | XLY | 3.3% | 3.8% | -27.6% | -55% |
| Consumer Staples | XLP | 2.5% | 6.3% | -36.9% | -46% |
| Energy | XLE | 2.5% | -0.1% | -31.1% | -37% |
| Financial | XLF | 2.1% | 1.9% | -40.1% | -68% |
| Health Care | XLV | 3.4% | 4.8% | -27.9% | -33% |
| Industrial | XLI | 2.7% | 2.7% | -43.1% | -63% |
| Materials | XLB | 0.6% | 2.7% | -39.7% | -44% |
| Real Estate | XLRE | 2.9% | 6% | -34.9% | -50% |
| Technology | XLK | 2.1% | -1.8% | -37.5% | -49% |
| Utilities | XLU | 3.9% | 5.2% | -38.4% | -60% |
| Aerospace & Defense | XAR | 4.9% | -0.1% | -53.8% | -87% |
| Biotech | XBI | 1.8% | 3.6% | -22% | -31% |
| Homebuilder | XHB | 0.3% | -0.1% | -28% | -43% |
| Retail | XRT | 0.3% | 2% | -30.9% | -49% |
CYTK vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 1.9% | -1.50% | -26.8% | -30% |
| Natural Gas | UNG | 12.3% | 16.8% | -18.4% | -35% |
| Gold | GLD | 2.6% | 8.2% | -55.8% | -77% |
| Silver | SLV | 1.8% | 0% | -52.6% | -55% |
| Copper | CPER | 3.8% | 2.4% | -52.3% | -48% |
CYTK vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 4.6% | 5.9% | -31.8% | -36% |
| iShares High Yield Corp. Bond | HYG | 4% | 5.3% | -34.1% | -48% |